Andy Chen
Stock Analyst at Wolfe Research
Total Price Targets
10
Stocks Covered
9
Sectors
Healthcare
Most Recent
Apr 8, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Andy Chen
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| DNTH | Dianthus Therapeutics, Inc. | $98.00 | $87.86 | +11.5% | 1 | Apr 8, 2026 |
| MDGL | Madrigal Pharmaceuticals, Inc. | $579.00 | $516.66 | +12.1% | 1 | Jan 6, 2026 |
| INSM | Insmed Incorporated | $167.00 | $133.75 | +24.9% | 2 | Dec 18, 2025 |
| ORKA | Oruka Therapeutics, Inc. | $20.00 | $62.83 | -68.2% | 1 | Feb 4, 2025 |
| ANAB | AnaptysBio, Inc. | $25.00 | $66.67 | -62.5% | 1 | Feb 4, 2025 |
| INCY | Incyte Corporation | $84.00 | $96.41 | -12.9% | 1 | Sep 30, 2024 |
| KYMR | Kymera Therapeutics, Inc. | $65.00 | $81.54 | -20.3% | 1 | Aug 26, 2024 |
| VRTX | Vertex Pharmaceuticals Incorporated | $576.00 | $425.06 | +35.5% | 1 | Aug 5, 2024 |
| VRDN | Viridian Therapeutics, Inc. | $14.50 | $13.41 | +8.1% | 1 | Jun 10, 2024 |
Recent Activity
- Apr 8, 2026— Set$98.00price target onDNTH(Dianthus Therapeutics, Inc.)
- Jan 6, 2026— Set$579.00price target onMDGL(Madrigal Pharmaceuticals, Inc.)
- Dec 18, 2025— Set$167.00price target onINSM(Insmed Incorporated)
- Feb 4, 2025— Set$20.00price target onORKA(Oruka Therapeutics, Inc.)
- Feb 4, 2025— Set$25.00price target onANAB(AnaptysBio, Inc.)
- Sep 30, 2024— Set$84.00price target onINCY(Incyte Corporation)
- Aug 26, 2024— Set$65.00price target onKYMR(Kymera Therapeutics, Inc.)
- Aug 5, 2024— Set$576.00price target onVRTX(Vertex Pharmaceuticals Incorporated)
- Jun 10, 2024— Set$14.50price target onVRDN(Viridian Therapeutics, Inc.)
- May 29, 2024— Set$54.00price target onINSM(Insmed Incorporated)
Frequently Asked Questions
Who is Andy Chen?
Andy Chen is a stock analyst at Wolfe Research covering 9 stocks primarily in Healthcare. They have issued 10 price targets since May 29, 2024.
What stocks does Andy Chen cover?
Andy Chen currently covers 9 stocks, including INSM, DNTH, MDGL, ORKA, ANAB.
What is Andy Chen's latest price target?
Andy Chen's most recent price target was $98.00 on DNTH (Dianthus Therapeutics, Inc.), set on Apr 8, 2026.
What is Andy Chen's highest price target?
Andy Chen's highest issued price target is $579.00 on MDGL, set on Jan 6, 2026.
More Analysts at Wolfe Research
Coverage based on publicly published price targets. Not investment advice.